HOMA-IR Calculator
Estimate insulin resistance from fasting glucose and insulin – and see why a normal glucose result can still hide it.
What HOMA-IR measures, and why glucose alone misses it
HOMA-IR estimates how much insulin your body needs to keep blood sugar steady. After a fast, glucose and insulin hold each other in a feedback loop, and the model behind HOMA turns one pair of fasting values into an estimate of insulin resistance.[1]
This matters because the body compensates. When cells respond poorly to insulin, the pancreas releases more of it, and fasting glucose can stay normal while insulin is already high. In the Whitehall II cohort, estimated insulin sensitivity fell sharply over the five years before type 2 diabetes was diagnosed, while fasting glucose rose steeply only in the last three.[3]
Take two hypothetical adults, both with a fasting glucose of 92 mg/dL, a perfectly normal result. One has a fasting insulin of 4 µIU/mL, the other 18. Their HOMA-IR values are 0.9 and 4.1. A glucose test cannot tell them apart. Insulin can.
HOMA-IR is an estimate from one fasting blood draw. It is a way to look at the pattern, not a diagnosis.
How HOMA-IR is calculated
You need two values from the same fasting blood draw. The formula has two forms, depending on the units on your lab report:
- Glucose in mg/dL: glucose × insulin (µIU/mL) ÷ 405
- Glucose in mmol/L: glucose × insulin (µIU/mL) ÷ 22.5
Example: a fasting glucose of 92 mg/dL (5.1 mmol/L) and a fasting insulin of 8 µIU/mL give 92 × 8 ÷ 405 = 1.8. If your lab reports insulin in pmol/L, divide by 6.945 to get µIU/mL; the calculator does this when you switch to SI units.
The simple formula is a shortcut. It approximates the original 1985 computer model and was calibrated to an insulin assay from the 1970s, so absolute values can differ from those of newer assays and of the updated HOMA2 model. The model’s authors consider it still useful for following change over time.[1][2] Almost every online calculator, including this one, uses the simple formula, so treat the result as an estimate.
What your result means
There is no single HOMA-IR cutoff for insulin resistance. The authors of the HOMA model gave none: they say each population needs its own normal baseline.[2] A 2025 meta-analysis of 87 studies and 235,148 adults found cutoffs mostly between 2.0 and 2.7, and the share of adults classed as insulin resistant moved from about 28% at cutoffs of 2.5 or lower to about 25% above 3.0.[8] Individual studies set it anywhere from about 1.5 to nearly 4, depending on who was studied and how the line was drawn:[4]
| Population | Cutoff | How it was set |
|---|---|---|
| Thailand, adults with normal BMI and glucose | 1.55 | 90th percentile |
| Japan, healthy adults | 1.7 | 90th percentile |
| Sweden, general population | 2.0 | 75th percentile |
| Spain, general population | 2.0 | ROC analysis |
| United States (NHANES), adults with normal BMI and glucose | 2.73 | 66th percentile |
| Brazil | 2.77 | 90th percentile |
| France, general population | 3.8 | 75th percentile |
In the Spanish EPIRCE study of 2,459 adults, the cutoff that best flagged metabolic syndrome was 2.05, and 1.85 in men without diabetes. The authors found that in women the right threshold changes with age.[4]
What this means for you:
- Below about 1.5. Under every cutoff in the table.
- About 1.5 to 2.7. A gray zone. Above the lower cutoffs, below the higher ones. The same number can be flagged in one study and normal in another.
- About 2.7 to 3.8. Above most published cutoffs, and the one to bring to a doctor, together with your other results.
- Above 3.8. Above every cutoff in the table.
Treat these bands as a way to read your number against the literature, not as a diagnosis. Type 2 diabetes is diagnosed from glucose and HbA1c, not from HOMA-IR.[5]
What can skew the result
- Not fasted. Eating raises insulin within minutes, which pushes HOMA-IR up. Both values must come from the same sample after a fast of at least 8 hours.[5]
- A different lab or assay. Insulin assays differ, and the 1985 formula was calibrated to a 1970s assay. Reported variability of insulin measurement can be large.[2] Repeat tests at the same lab where you can.
- Diabetes or insulin treatment. The model assumes the pancreas regulates insulin on its own, so it is not supported for people who take insulin.[2]
- Acute illness or stress. HOMA assumes a steady fasting state and is not supported when glucose is changing, for example during an acute illness.[2]
- Who you are. Cutoffs differ by population, sex and age, as the table above shows.[4]
One result is one data point. A trend over repeated, comparable tests says more than a single value.
HOMA-IR next to other blood tests
No single marker covers the whole picture. Each one sees a different part of it:
| Test | What it shows | What it misses |
|---|---|---|
| Fasting glucose | Blood sugar now. 100 to 125 mg/dL is the prediabetes range.[5] | Insulin resistance that the pancreas is still compensating for.[3] |
| HbA1c | Average blood sugar over two to three months. 5.7% to 6.4% is the prediabetes range.[5] | The same: it rises after the compensation starts to fail. |
| Fasting insulin | How much insulin it takes to hold glucose steady. | On its own it has no agreed reference range. Needs glucose next to it. |
| HOMA-IR | Insulin and glucose together, as one estimate of insulin resistance. | Depends on the assay, the fast and who you are (see above). |
| Triglycerides and HDL | Two of the five criteria of metabolic syndrome: triglycerides of 150 mg/dL or higher, HDL below 40 (men) or 50 (women).[6] | They show the metabolic effect, not insulin directly. |
So the most informative set is glucose, insulin and HbA1c together, with triglycerides and HDL for the blood-fat side. Our BMI calculator covers the weight side of the same picture.
What lowers insulin resistance
The strongest evidence is for preventing type 2 diabetes in adults who already have elevated blood sugar. In the Diabetes Prevention Program, 3,234 adults with an average BMI of 34 were assigned to a lifestyle program aiming for at least 7% weight loss and 150 minutes of physical activity a week. Over about 2.8 years it cut new cases of type 2 diabetes by 58% compared with placebo. Metformin cut them by 31%.[7]
The lifestyle goal was modest: for someone who weighs 200 lb, 7% is 14 lb. The trial measured diabetes, not HOMA-IR, so it shows that the changes work, not by how many points your value will fall.
After a sustained change, repeat glucose and insulin at the same lab to see whether your own numbers moved. If you take a medication that affects blood sugar, do not stop it to improve a result: talk to the doctor who prescribed it.
When to talk to a doctor
Bring your results to a doctor if any of these apply:
- Your HOMA-IR is in the upper part of the table above, or keeps rising across repeat tests.
- Your fasting glucose is 100 mg/dL or higher, or your HbA1c is 5.7% or higher.[5]
- You meet three or more of the five metabolic syndrome criteria.[6]
- Type 2 diabetes runs in your family and you have excess weight around the waist.
- You have symptoms such as unusual thirst, frequent urination or fatigue that does not go away.
Note: Information provided in this article is for educational purposes and doesn’t replace personalized medical advice.
Frequently Asked Questions
There is no single normal value. Studies in different countries set the cutoff between about 1.5 and 3.8, so the same result can look normal in one population and high in another.[4] Read your number against the table above, and with your other results.
It suggests your body needs more insulin than average to keep blood sugar steady. It is not a diagnosis, and it can be influenced by the lab, the fast and your age.[2][4] A doctor reads it together with glucose, HbA1c and your health history.
Multiply fasting glucose in mg/dL by fasting insulin in µIU/mL and divide by 405. With glucose in mmol/L, divide by 22.5 instead.[1] The calculator above does it for you.
Fasting glucose and fasting insulin from the same blood draw. HbA1c, triglycerides and HDL cholesterol add context.[5][6]
Yes. The body can compensate by making more insulin, so glucose stays normal while insulin is high. In the Whitehall II cohort, insulin sensitivity fell years before fasting glucose rose steeply.[3]
No. These are diagnosed with fasting glucose, HbA1c or a glucose tolerance test.[5]
The best-studied approach is a modest weight loss of about 7% with regular physical activity: in the Diabetes Prevention Program it cut new diabetes cases by 58%.[7] A doctor can help you choose what fits you.
Insulin assays are not identical, and the 1985 formula was calibrated to a 1970s assay.[2] Compare results from the same lab when you can.
References
Key Sources:
- Matthews DR, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883
- Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495. doi:10.2337/diacare.27.6.1487
- Tabák AG, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373(9682):2215–2221. doi:10.1016/S0140-6736(09)60619-X
- Gayoso-Diz P, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. 2013;13:47. doi:10.1186/1472-6823-13-47
- American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S27–S49. doi:10.2337/dc26-S002
- Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome. Circulation. 2009;120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644
- Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. doi:10.1056/NEJMoa012512
- Ballena-Caicedo J, Zuzunaga-Montoya FE, Loayza-Castro JA, et al. Global prevalence of insulin resistance in the adult population: a systematic review and meta-analysis. Front Endocrinol. 2025;16:1646258. doi:10.3389/fendo.2025.1646258